Jeffrey G. Lamothe Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey G. Lamothe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey G. Lamothe. Jeffrey G. Lamothe is SVP and CFO in Aptevo Therapeutics Inc. ($APVO) and SVP, CFO and Treasurer in Aptevo Therapeutics Inc. ($APVO).
Latest Insider Trading Transactions of Jeffrey G. Lamothe
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 0.00 | 5,500 | 0 | 5,500 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 33.50 | 16,500 | 552,750 | 16,500 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 7,380 | 63,173 | 7,380 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 7,380 | 63,173 | 7,380 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 41.58 | 3,128 | 130,062 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 35.70 | 1,928 | 68,830 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 41.58 | 3,128 | 130,062 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 34.58 | 2,695 | 93,193 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 35.70 | 1,928 | 68,830 | 0 | |
Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 34.58 | 2,695 | 93,193 | 0 | |
Mar 19 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 0.50 | 134,800 | 67,130 | 134,800 | |
Nov 05 2019 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | A | 0.58 | 135,384 | 77,981 | 135,384 | |
Mar 04 2019 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | M | 0.00 | 7,318 | 0 | 0 | |
Mar 04 2019 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 1.52 | 67,400 | 102,448 | 67,400 | |
Mar 04 2019 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Payment of Exercise | F | 1.57 | 2,170 | 3,407 | 75,024 | 77.2 K to 75 K (-2.81 %) |
Mar 04 2019 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Buy | M | 0.00 | 7,318 | 0 | 77,194 | 69.9 K to 77.2 K (+10.47 %) |
Mar 13 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 6,747 | 0 | 7,318 | |
Mar 13 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | A | 3.13 | 67,400 | 210,962 | 67,400 | |
Mar 13 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 3.13 | 1,583 | 4,955 | 69,876 | 71.5 K to 69.9 K (-2.22 %) |
Mar 13 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 6,747 | 0 | 71,459 | 64.7 K to 71.5 K (+10.43 %) |
Mar 05 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 7,320 | 0 | 14,065 | |
Mar 05 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 3.04 | 1,717 | 5,220 | 64,712 | 66.4 K to 64.7 K (-2.58 %) |
Mar 05 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 7,320 | 0 | 66,429 | 59.1 K to 66.4 K (+12.38 %) |
Feb 06 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 25,340 | 0 | 21,385 | |
Feb 06 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 3.24 | 7,514 | 24,345 | 59,109 | 66.6 K to 59.1 K (-11.28 %) |
Feb 06 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 25,340 | 0 | 66,623 | 41.3 K to 66.6 K (+61.38 %) |
Jun 01 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | A | 2.15 | 33,700 | 72,455 | 33,700 | |
Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 18,863 | 0 | 46,725 | |
Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 6,746 | 0 | 65,588 | |
Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 7,320 | 0 | 72,334 | |
Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 1.78 | 4,990 | 8,882 | 41,284 | 46.3 K to 41.3 K (-10.78 %) |
Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 18,863 | 0 | 46,274 | 27.4 K to 46.3 K (+68.82 %) |
Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 1.78 | 1,785 | 3,177 | 27,411 | 29.2 K to 27.4 K (-6.11 %) |
Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 6,746 | 0 | 29,196 | 22.5 K to 29.2 K (+30.05 %) |
Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 2.02 | 1,936 | 3,911 | 22,450 | 24.4 K to 22.5 K (-7.94 %) |
Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 7,320 | 0 | 24,386 | 17.1 K to 24.4 K (+42.89 %) |
Feb 27 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | A | 1.96 | 33,700 | 66,052 | 142,232 | |
Feb 08 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 25,340 | 0 | 79,654 | |
Feb 08 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 1.92 | 8,274 | 15,886 | 17,066 | 25.3 K to 17.1 K (-32.65 %) |
Feb 08 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 25,340 | 0 | 25,340 | 0 to 25.3 K |
Aug 05 2016 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | A | 0.00 | 50,680 | 0 | 50,680 |
Page: 1